[Federal Register Volume 60, Number 220 (Wednesday, November 15, 1995)]
[Notices]
[Page 57528]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-28244]




[[Page 57527]]

_______________________________________________________________________

Part V





Department of Health and Human Services





_______________________________________________________________________



National Institutes of Health



_______________________________________________________________________



Recombinant DNA Advisory Committee and Research; Notice of Meeting and 
Proposed Actions Under the Guidelines; Notices

  Federal Register / Vol. 60, No. 220 / Wednesday, November 15, 1995 / 
Notices  

[[Page 57528]]


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Recombinant DNA Advisory Committee; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given of a meeting 
of the Recombinant DNA Advisory Committee on December 4-5, 1995. The 
meeting will be held at the National Institutes of Health, Building 
31C, 6th Floor, Conference Room 10, 9000 Rockville Pike, Bethesda, 
Maryland 20892, starting on December 4, 1995, at approximately 9 a.m., 
and will recess at approximately 5 p.m. The meeting will reconvene on 
December 5, 1995, at approximately 8:30 a.m. and will adjourn at 
approximately 5 p.m. The meeting will be open to the public to discuss 
Proposed Actions under the NIH Guidelines for Research Involving 
Recombinant DNA Molecules (59 FR 34496) and other matters to be 
considered by the Committee. The Proposed Actions to be discussed will 
follow this notice of meeting. Attendance by the public will be limited 
to space available. Members of the public wishing to speak at this 
meeting may be given such opportunity at the discretion of the Chair.
    Dr. Nelson A. Wivel, Director, Office of Recombinant DNA 
Activities, National Institutes of Health, MSC 7010, 6000 Executive 
Boulevard, Suite 302, Bethesda, Maryland 20892-7010, Phone (301) 496-
9838, FAX (301) 496-9839, will provide materials to be discussed at 
this meeting, roster of committee members, and substantive program 
information. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
recommendations, should contact Dr. Wivel in advance of the meeting. A 
summary of the meeting will be available at a later date.
    OMB's ``Mandatory Information Requirements for Federal Assistance 
Program Announcements'' (45 FR 39592, June 11, 1980) requires a 
statement concerning the official government programs contained in the 
Catalog of Federal Domestic Assistance. Normally NIH lists in its 
announcements the number and title of affected individual programs for 
the guidance of the public. Because the guidance in this notice covers 
not only virtually every NIH program but also essentially every Federal 
research program in which DNA recombinant molecule techniques could be 
used, it has been determined not to be cost effective or in the public 
interest to attempt to list these programs. Such a list would likely 
require several additional pages. In addition, NIH could not be certain 
that every Federal program would be included as many Federal agencies, 
as well as private organizations, both national and international, have 
elected to follow the NIH Guidelines. In lieu of the individual program 
listing, NIH invites readers to direct questions to the information 
address above about whether individual programs listed in the Catalog 
of Federal Domestic Assistance are affected.

    Dated: November 9, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-28244 Filed 11-14-95; 8:45 am]
BILLING CODE 4140-01-M